Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer

CONCLUSION: Plasma TrxR activity can be used as a suitable biomarker for breast cancer diagnosis and efficacy assessment.PMID:38616444 | DOI:10.1016/j.clbc.2024.03.008

Source: Clinical Breast Cancer - April 15, 2024 Category: Cancer & Oncology Authors: Yixuan Hu Yinxing Zhu Junfeng Shi Xiaowei Wei Cuiju Tang Xiaoxiang Guan Wenwen Zhang Source Type: research